<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15130">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02130908</url>
  </required_header>
  <id_info>
    <org_study_id>REK2011/572</org_study_id>
    <nct_id>NCT02130908</nct_id>
  </id_info>
  <brief_title>A Study on the Possible Health Effects of Lean Fish, Fatty Fish and Lean Meat Intake in Non-obese Adults</brief_title>
  <acronym>FISK1</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a pilot study to investigate whether intake of lean or fatty fish, or lean
      meat would affect parameters related to health in healthy non-obese adults, and will serve
      as basis for future calculation of group sizes in coming studies. Participants consumed
      750g/week of fillets of fish or meat for 8 weeks.

      Hypotheses:

        1. High intake of either lean or fatty fish would improve serum concentrations of lipids
           and inflammatory markers as well as improve glucose tolerance during the 4 week
           intervention period.

        2. High intake of lean meat would not affect the serum levels of lipids, inflammatory
           markers and glucose.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2011</start_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)</study_design>
  <primary_outcome>
    <measure>Changes in metabolic parameters (lipids, glucose, inflammatory markers) measured in serum</measure>
    <time_frame>Endpoint after 8 weeks intervention</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in body weight</measure>
    <time_frame>Endpoint after 8 weeks intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Metabolic Disorders</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lean fish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fatty fish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean meat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lean fish</intervention_name>
    <description>Participants consumed 150g of lean fish, five times per week for 8 weeks</description>
    <arm_group_label>Lean fish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fatty fish</intervention_name>
    <description>Participants consumed 150g of fatty fish, five times per week for 8 weeks</description>
    <arm_group_label>Fatty fish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lean meat</intervention_name>
    <description>Participants consumed 150g of lean meat, five times per week for 8 weeks</description>
    <arm_group_label>Lean meat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults

          -  non-obese

          -  healthy

        Exclusion Criteria:

          -  diabetes

          -  diagnosed diseases of the intestine or cardiovacular system
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 5, 2014</lastchanged_date>
  <firstreceived_date>May 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bergen</investigator_affiliation>
    <investigator_full_name>Oddrun Anita Gudbrandsen</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
